Service Change: DepoMed Changes Name to Assertio

Assertio Therapeutics, Inc. (NASDAQ: ASRT), announced that its corporate name changes from “Depomed, Inc.” to “Assertio Therapeutics, Inc.”

LAKE FOREST, Ill., Aug. 15, 2018 (GLOBE NEWSWIRE) –Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty pharmaceutical company committed to advancing patient care, has announced that its corporate name changes from “Depomed, Inc.” to “Assertio Therapeutics, Inc.” became effective at 11:59 p.m. ET yesterday, August 14, 2018. In connection with the name change, the Company’s common stock will begin trading under a new ticker symbol “ASRT” and a new CUSIP number, 04545L 107, at the opening of trading today.

Posted by Steven Albrecht